Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-12
DOI
10.1038/s41598-020-74083-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- O-GlcNAc Transferase Regulates Cancer Stem–like Potential of Breast Cancer Cells
- (2020) Neha M. Akella et al. MOLECULAR CANCER RESEARCH
- Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
- (2020) Harri M. Itkonen et al. MOLECULAR CANCER RESEARCH
- Nutrient Regulation of Signaling & Transcription
- (2019) Gerald W. Hart JOURNAL OF BIOLOGICAL CHEMISTRY
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes
- (2019) Anna Barkovskaya et al. Scientific Reports
- Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical Trials
- (2019) Rola El Sayed et al. Frontiers in Oncology
- O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth
- (2019) Jay Prakash Singh et al. ONCOGENE
- Toward understanding the origin and evolution of cellular organisms
- (2019) Minoru Kanehisa PROTEIN SCIENCE
- Mitochondrial fragmentation, elevated mitochondrial superoxide and respiratory supercomplexes disassembly is connected with the tamoxifen-resistant phenotype of breast cancer cells
- (2019) Veronika Tomková et al. FREE RADICAL BIOLOGY AND MEDICINE
- Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation
- (2018) Junmei Cairns et al. EMBO REPORTS
- O-GlcNAcylation Signal Mediates Proteasome Inhibitor Resistance in Cancer Cells by Stabilizing NRF1
- (2018) Hiroki Sekine et al. MOLECULAR AND CELLULAR BIOLOGY
- Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
- (2018) Ádám Nagy et al. Scientific Reports
- Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivity
- (2018) Hao Shi et al. Molecular Metabolism
- Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors
- (2018) Sara E. S. Martin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- New approach for understanding genome variations in KEGG
- (2018) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Adipocyte OGT governs diet-induced hyperphagia and obesity
- (2018) Min-Dian Li et al. Nature Communications
- Calcium-dependent O-GlcNAc signaling drives liver autophagy in adaptation to starvation
- (2017) Hai-Bin Ruan et al. GENES & DEVELOPMENT
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- Protein O-GlcNAcylation: emerging mechanisms and functions
- (2017) Xiaoyong Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation
- (2017) V L Sodi et al. ONCOGENE
- Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
- (2017) Marco Fiorillo et al. Oncotarget
- Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
- (2017) Alfonso Urbanucci et al. Cell Reports
- O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer
- (2017) Gloria M. Trinca et al. Hormones & Cancer
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment
- (2016) N. A. Daurio et al. CANCER RESEARCH
- Roles of O-GlcNAc in chronic diseases of aging
- (2016) Partha S. Banerjee et al. MOLECULAR ASPECTS OF MEDICINE
- O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway
- (2016) C M Ferrer et al. ONCOGENE
- The nutrient sensor OGT in PVN neurons regulates feeding
- (2016) O. Lagerlof et al. SCIENCE
- Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
- (2016) Harri M. Itkonen et al. Oncotarget
- A Small Molecule That Inhibits OGT Activity in Cells
- (2015) Rodrigo F. Ortiz-Meoz et al. ACS Chemical Biology
- dbSUPER: a database of super-enhancers in mouse and human genome
- (2015) Aziz Khan et al. NUCLEIC ACIDS RESEARCH
- O-GlcNAcylation Regulates Cancer Metabolism and Survival Stress Signaling via Regulation of the HIF-1 Pathway
- (2014) Christina M. Ferrer et al. MOLECULAR CELL
- O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells
- (2013) H. M. Itkonen et al. CANCER RESEARCH
- TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS
- (2013) Rachel Deplus et al. EMBO JOURNAL
- Proteomic analysis and abrogated expression ofO-GlcNAcylated proteins associated with primary breast cancer
- (2013) Voraratt Champattanachai et al. PROTEOMICS
- Evidence of the Involvement ofO-GlcNAc-modified Human RNA Polymerase II CTD in Transcriptionin Vitroandin Vivo
- (2012) Stella M. Ranuncolo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection
- (2012) Kevin A. Kwei et al. PLoS One
- O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1
- (2011) Francesca Capotosti et al. CELL
- Gene expression of O-GlcNAc cycling enzymes in human breast cancers
- (2011) Anna Krześlak et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells
- (2011) Tracey M Gloster et al. Nature Chemical Biology
- Management of breast cancer with targeted agents: importance of heterogenicity
- (2010) Serena Di Cosimo et al. Nature Reviews Clinical Oncology
- Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1
- (2010) S A Caldwell et al. ONCOGENE
- Toxic Effects of Hyperglycemia Are Mediated by the Hexosamine Signaling Pathway and O-Linked Glycosylation in Early Mouse Embryos1
- (2009) Marie Pantaleon et al. BIOLOGY OF REPRODUCTION
- Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
- (2008) S. Massarweh et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started